Paixão, S.V.M. and Silva, C.D.C.M. 2024. Lutetium-specific prostatic membrane antigen (luPSMA) treatment for metastatic castration- resistant prostate cancer. LUMEN ET VIRTUS. 15, 38 (Jul. 2024), 942–954. DOI:https://doi.org/10.56238/levv15n38-060.